UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$453M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$287M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$284M |
| 4 |
PPL
PPL Corp
PPL
|
+$262M |
| 5 |
Western Digital
WDC
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$477M |
| 3 |
Accenture
ACN
|
+$354M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$332M |
| 5 |
Chevron
CVX
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Healthcare | 7.02% |
| 3 | Financials | 6.95% |
| 4 | Consumer Discretionary | 5.19% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Inovio Pharmaceuticals
INO
$80M
| $1.05M | ﹤0.01% |
50,354
-86,314
| -63% | -$2.43M |
|
3702
Doximity
DOCS
$4.66B
| $1.04M | ﹤0.01% |
30,007
-57,565
| -66% | -$2.27M |
|
3703
Iovance Biotherapeutics
IOVA
$2.89B
| $1.04M | ﹤0.01% |
94,639
-265,107
| -74% | -$3.47M |
|
|
CSSE
3704
PUT
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $1.04M | ﹤0.01% |
+141,000
| New | +$1.08M |
|
|
MYOV
3705
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.04M | ﹤0.01% |
84,068
-67,713
| -45% | -$747K |
|
3706
Coca-Cola Consolidated
COKE
$12B
| $1.04M | ﹤0.01% |
18,460
+10,420
| +130% | +$544K |
|
3707
Chesapeake Utilities
CPK
$3.23B
| $1.04M | ﹤0.01% |
8,036
+567
| +8% | +$74K |
|
3708
Green Brick Partners
GRBK
$3.09B
| $1.04M | ﹤0.01% |
53,190
-6,315
| -11% | -$133K |
|
3709
Rackspace Technology
RXT
$1.16B
| $1.04M | ﹤0.01% |
145,219
+60,575
| +72% | +$546K |
|
3710
Krystal Biotech
KRYS
$9.63B
| $1.04M | ﹤0.01% |
15,834
-42,236
| -73% | -$2.63M |
|
3711
NOV
NOV
$7.45B
| $1.04M | ﹤0.01% |
61,471
+1,166
| +2% | +$21.9K |
|
3712
Endava
DAVA
$159M
| $1.04M | ﹤0.01% |
11,752
-7,616
| -39% | -$797K |
|
3713
Invesco Oil & Gas Services ETF
PXJ
$64.5M
| $1.04M | ﹤0.01% |
54,581
-99,466
| -65% | -$2.21M |
|
|
MAG
3714
CALL
DELISTED
MAG Silver
MAG
| $1.04M | ﹤0.01% |
85,200
+43,700
| +105% | +$640K |
|
3715
Ralph Lauren
RL
$23.8B
| $1.04M | ﹤0.01% |
11,547
-65,873
| -85% | -$6.65M |
|
3716
United Natural Foods
UNFI
$2.87B
| $1.03M | ﹤0.01% |
26,262
-14,226
| -35% | -$598K |
|
3717
FlexShares Ultra-Short Income Fund
RAVI
$1.5B
| $1.03M | ﹤0.01% |
13,877
-10,866
| -44% | -$811K |
|
|
STEW
3718
SRH Total Return Fund
STEW
$1.81B
| $1.03M | ﹤0.01% |
86,336
+1,671
| +2% | +$22.1K |
|
3719
Graham Holdings Company
GHC
$4.97B
| $1.03M | ﹤0.01% |
1,815
-653
| -26% | -$389K |
|
3720
PGIM Ultra Short Bond ETF
PULS
$18.4B
| $1.03M | ﹤0.01% |
20,941
+15,318
| +272% | +$753K |
|
3721
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$532M
| $1.03M | ﹤0.01% |
18,006
+6
| +0% | +$356 |
|
|
XFIN
3722
DELISTED
ExcelFin Acquisition Corp Class A Common Stock
XFIN
| $1.03M | ﹤0.01% |
103,360
+1,000
| +1% | +$9.95K |
|
3723
Nuveen Core Equity Alpha Fund
JCE
$290M
| $1.02M | ﹤0.01% |
76,747
-711
| -0.9% | -$10.4K |
|
|
BTO
3724
John Hancock Financial Opportunities Fund
BTO
$809M
| $1.02M | ﹤0.01% |
27,580
-2,644
| -9% | -$97.4K |
|
|
PNF
3725
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $1.02M | ﹤0.01% |
111,739
-18,999
| -15% | -$176K |
|
Similar funds
UBS Group's Q2 2022 Portfolio in Review
As of Q2 2022, UBS Group held 11,816 positions worth $244B, down 19% from $300B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $9.23B in Q2 2022, closing 1,052 positions and reducing 5,054 holdings. Its most notable exit was Cerner Corp, an estimated $177M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS Group opened a new position in iShares 0-3 Month Treasury Bond ETF worth $13.8M.
- UBS Group's largest Q2 2022 buy was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $453M increase.
- UBS Group's biggest Q2 2022 reduction was Apple, cutting an estimated $641M.
- UBS Group fully exited Cerner Corp in Q2 2022, selling an estimated $177M.
- UBS Group's ten largest holdings make up 13% of its $244B portfolio in Q2 2022.
- UBS Group opened 1,264 new positions and closed 1,052 in Q2 2022.
- UBS Group's portfolio value fell 19% quarter-over-quarter to $244B.
Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.